CLAIM #11925 · Bristol-Myers Squibb Company (BMY) · 2024Q1 earnings call · Apr 25, 2024 · due Dec 31, 2025
“We're hopeful that we have an opportunity to launch there sometime in the back end of this year and into next year.”
Adam Lenkowsky · Chief Commercialization Officer
PENDING
graded after results covering Dec 31, 2025 are reported
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2024Q1 earnings call.